> top > docs > PubMed:16135558 > annotations

PubMed:16135558 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 369-375 https://glytoucan.org/Structures/Glycans/G81533KY denotes Neu5Ac
T2 476-487 https://glytoucan.org/Structures/Glycans/G81533KY denotes sialic acid
T3 774-791 https://glytoucan.org/Structures/Glycans/G08371CD denotes sialyl-Tn antigen
T4 774-791 https://glytoucan.org/Structures/Glycans/G36123IU denotes sialyl-Tn antigen

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 369-375 Glycan_Motif denotes Neu5Ac https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY
T2 476-487 Glycan_Motif denotes sialic acid https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY
T3 774-791 Glycan_Motif denotes sialyl-Tn antigen https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G36123IU|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G08371CD
T5 781-791 Glycan_Motif denotes Tn antigen https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI
T6 793-796 Glycan_Motif denotes STn https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G36123IU
T7 1141-1144 Glycan_Motif denotes STn https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G36123IU

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
TextSentencer_T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
TextSentencer_T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
TextSentencer_T4 557-645 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn.
TextSentencer_T5 646-809 Sentence denotes We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
TextSentencer_T6 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
TextSentencer_T7 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
TextSentencer_T8 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
TextSentencer_T9 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.
T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
T4 557-809 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn. We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
T5 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
T6 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
T7 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
T8 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.
T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
T4 557-645 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn.
T5 646-809 Sentence denotes We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
T6 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
T7 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
T8 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
T9 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 369-375 https://glytoucan.org/Structures/Glycans/G81533KY denotes Neu5Ac
T2 476-487 https://glytoucan.org/Structures/Glycans/G81533KY denotes sialic acid
T3 774-791 https://glytoucan.org/Structures/Glycans/G08371CD denotes sialyl-Tn antigen
T4 774-791 https://glytoucan.org/Structures/Glycans/G36123IU denotes sialyl-Tn antigen
T5 781-791 https://glytoucan.org/Structures/Glycans/G57321FI denotes Tn antigen

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 774-791 http://www.glycoepitope.jp/epitopes/EP0022 denotes sialyl-Tn antigen
T2 781-791 http://www.glycoepitope.jp/epitopes/EP0021 denotes Tn antigen
T3 793-796 http://www.glycoepitope.jp/epitopes/EP0022 denotes STn
T4 1141-1144 http://www.glycoepitope.jp/epitopes/EP0022 denotes STn

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 212-219 HP_0002664 denotes cancers
T2 231-244 HP_0003002 denotes breast cancer
T3 231-244 HP_0100013 denotes breast cancer
T4 238-244 HP_0002664 denotes cancer
T5 578-591 HP_0003002 denotes breast cancer
T6 578-591 HP_0100013 denotes breast cancer
T7 585-591 HP_0002664 denotes cancer
T8 719-732 HP_0003002 denotes breast cancer
T9 719-732 HP_0100013 denotes breast cancer
T10 726-732 HP_0002664 denotes cancer
T11 1182-1188 HP_0002664 denotes tumour
T12 1199-1231 HP_0004430 denotes severe combined immunodeficiency
T13 1206-1231 HP_0005387 denotes combined immunodeficiency
T14 1215-1231 HP_0002721 denotes immunodeficiency
T15 1415-1428 HP_0003002 denotes breast cancer
T16 1415-1428 HP_0100013 denotes breast cancer
T17 1422-1428 HP_0002664 denotes cancer

ICD10

Id Subject Object Predicate Lexical cue
T1 1206-1231 http://purl.bioontology.org/ontology/ICD10/D81.9 denotes combined immunodeficiency
T2 1206-1231 http://purl.bioontology.org/ontology/ICD10/D81 denotes combined immunodeficiency
T3 1215-1231 http://purl.bioontology.org/ontology/ICD10/D84.9 denotes immunodeficiency

uniprot-human

Id Subject Object Predicate Lexical cue
T1 30-32 http://www.uniprot.org/uniprot/P02144 denotes MB
T2 703-705 http://www.uniprot.org/uniprot/P02144 denotes MB
T3 928-930 http://www.uniprot.org/uniprot/P02144 denotes MB
T4 1123-1125 http://www.uniprot.org/uniprot/P02144 denotes MB
T5 1408-1410 http://www.uniprot.org/uniprot/P02144 denotes MB
T6 320-323 http://www.uniprot.org/uniprot/P21941 denotes CMP
T7 365-368 http://www.uniprot.org/uniprot/P21941 denotes CMP
T8 433-441 http://www.uniprot.org/uniprot/Q9NSC7 denotes 2.4.99.3
T9 578-596 http://www.uniprot.org/uniprot/Q8IZY5 denotes breast cancer cell
T10 719-737 http://www.uniprot.org/uniprot/Q8IZY5 denotes breast cancer cell
T11 879-883 http://www.uniprot.org/uniprot/Q9BXA4 denotes MUC1

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 433-441 http://www.uniprot.org/uniprot/Q9QZ39 denotes 2.4.99.3

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 44-50 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T2 51-56 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T3 212-219 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancers
T4 238-244 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T5 585-591 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T6 726-732 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T7 884-891 http://purl.bioontology.org/ontology/NCBITAXON/353209 denotes related
T8 954-959 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T9 1422-1428 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T10 1429-1434 http://purl.bioontology.org/ontology/STY/T025 denotes cells

GO-BP

Id Subject Object Predicate Lexical cue
T1 82-95 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T2 852-865 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T3 1299-1312 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T4 140-146 http://purl.obolibrary.org/obo/GO_0097503 denotes Sialyl
T5 290-296 http://purl.obolibrary.org/obo/GO_0097503 denotes Sialyl
T6 635-641 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T7 774-780 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T8 935-941 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T9 979-985 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T10 904-920 http://purl.obolibrary.org/obo/GO_0009306 denotes protein secreted
T11 912-920 http://purl.obolibrary.org/obo/GO_0046903 denotes secreted
T12 1189-1195 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-CC

Id Subject Object Predicate Lexical cue
T1 51-56 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T2 954-959 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3 592-596 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T4 733-737 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T5 394-397 http://purl.obolibrary.org/obo/GO_0005790 denotes Ser
T6 538-541 http://purl.obolibrary.org/obo/GO_0005790 denotes Ser
T7 631-634 http://purl.obolibrary.org/obo/GO_0005731 denotes nor

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 37-43 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T2 231-237 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T3 578-584 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T4 719-725 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T5 1415-1421 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

bionlp-st-epi-2011-training

Id Subject Object Predicate Lexical cue
T1 0-11 Protein denotes ST6GalNAc I
T2 444-455 Protein denotes ST6GalNAc I
T3 619-630 Protein denotes ST6GalNAc I
T4 749-760 Protein denotes ST6GalNAc I
T5 879-883 Protein denotes MUC1
T6 1332-1343 Protein denotes ST6GalNAc I

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 44-50 http://edamontology.org/topic_2640 denotes cancer
T2 155-167 http://edamontology.org/topic_0152 denotes carbohydrate
T3 168-175 http://edamontology.org/topic_2830 denotes antigen
T4 212-219 http://edamontology.org/topic_2640 denotes cancers
T5 238-244 http://edamontology.org/topic_2640 denotes cancer
T6 508-515 http://edamontology.org/topic_0102 denotes linkage
T7 585-591 http://edamontology.org/topic_2640 denotes cancer
T8 713-718 http://edamontology.org/topic_2815 denotes human
T9 726-732 http://edamontology.org/topic_2640 denotes cancer
T10 761-765 http://edamontology.org/topic_3512 denotes cDNA
T11 784-791 http://edamontology.org/topic_2830 denotes antigen
T12 904-911 http://edamontology.org/topic_0078 denotes protein
T13 1422-1428 http://edamontology.org/topic_2640 denotes cancer

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 430-432 http://edamontology.org/data_1011 denotes EC
T2 488-495 http://edamontology.org/data_1756 denotes residue
T3 546-555 http://edamontology.org/data_0883 denotes structure
T4 813-819 http://edamontology.org/data_2048 denotes report
T5 904-911 http://edamontology.org/format_1208 denotes protein
T6 904-911 http://edamontology.org/data_1467 denotes protein

Lectin

Id Subject Object Predicate Lexical cue
Lectin_T1 147-149 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T2 297-299 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T3 642-644 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T4 781-783 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T5 942-944 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T6 986-988 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 774-791 http://www.glycoepitope.jp/epitopes/EP0022 denotes sialyl-Tn antigen
PD-GlycoEpitope-B_T2 781-791 http://www.glycoepitope.jp/epitopes/EP0021 denotes Tn antigen

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 369-375 "http://rdf.glycoinfo.org/glycan/G76685HR" denotes Neu5Ac
GlycanIUPAC_T2 369-375 "http://rdf.glycoinfo.org/glycan/G65881BF" denotes Neu5Ac
GlycanIUPAC_T3 369-375 "http://rdf.glycoinfo.org/glycan/G82702MH" denotes Neu5Ac
GlycanIUPAC_T4 369-375 "http://rdf.glycoinfo.org/glycan/G51494MY" denotes Neu5Ac
GlycanIUPAC_T5 369-375 "http://rdf.glycoinfo.org/glycan/G37109XL" denotes Neu5Ac
GlycanIUPAC_T6 369-375 "http://rdf.glycoinfo.org/glycan/G47427MX" denotes Neu5Ac
GlycanIUPAC_T7 369-375 "http://rdf.glycoinfo.org/glycan/G89927NS" denotes Neu5Ac
GlycanIUPAC_T8 398-401 "http://rdf.glycoinfo.org/glycan/G69371PB" denotes Thr
GlycanIUPAC_T9 542-545 "http://rdf.glycoinfo.org/glycan/G69371PB" denotes Thr
GlycanIUPAC_T10 398-401 "http://rdf.glycoinfo.org/glycan/G04439TG" denotes Thr
GlycanIUPAC_T11 542-545 "http://rdf.glycoinfo.org/glycan/G04439TG" denotes Thr
GlycanIUPAC_T12 398-401 "http://rdf.glycoinfo.org/glycan/G01418RR" denotes Thr
GlycanIUPAC_T13 542-545 "http://rdf.glycoinfo.org/glycan/G01418RR" denotes Thr
GlycanIUPAC_T14 398-401 "http://rdf.glycoinfo.org/glycan/G98605AX" denotes Thr
GlycanIUPAC_T15 542-545 "http://rdf.glycoinfo.org/glycan/G98605AX" denotes Thr
GlycanIUPAC_T16 398-401 "http://rdf.glycoinfo.org/glycan/G24282OK" denotes Thr
GlycanIUPAC_T17 542-545 "http://rdf.glycoinfo.org/glycan/G24282OK" denotes Thr
GlycanIUPAC_T18 398-401 "http://rdf.glycoinfo.org/glycan/G55879EK" denotes Thr
GlycanIUPAC_T19 542-545 "http://rdf.glycoinfo.org/glycan/G55879EK" denotes Thr
GlycanIUPAC_T20 398-401 "http://rdf.glycoinfo.org/glycan/G12116BQ" denotes Thr
GlycanIUPAC_T21 542-545 "http://rdf.glycoinfo.org/glycan/G12116BQ" denotes Thr
GlycanIUPAC_T22 398-401 "http://rdf.glycoinfo.org/glycan/G54590PA" denotes Thr
GlycanIUPAC_T23 542-545 "http://rdf.glycoinfo.org/glycan/G54590PA" denotes Thr
GlycanIUPAC_T24 398-401 "http://rdf.glycoinfo.org/glycan/G31652HG" denotes Thr
GlycanIUPAC_T25 542-545 "http://rdf.glycoinfo.org/glycan/G31652HG" denotes Thr
GlycanIUPAC_T26 398-401 "http://rdf.glycoinfo.org/glycan/G15155WL" denotes Thr
GlycanIUPAC_T27 542-545 "http://rdf.glycoinfo.org/glycan/G15155WL" denotes Thr
GlycanIUPAC_T28 398-401 "http://rdf.glycoinfo.org/glycan/G52301ZX" denotes Thr
GlycanIUPAC_T29 542-545 "http://rdf.glycoinfo.org/glycan/G52301ZX" denotes Thr
GlycanIUPAC_T30 398-401 "http://rdf.glycoinfo.org/glycan/G04075BC" denotes Thr
GlycanIUPAC_T31 542-545 "http://rdf.glycoinfo.org/glycan/G04075BC" denotes Thr
GlycanIUPAC_T32 398-401 "http://rdf.glycoinfo.org/glycan/G40829OF" denotes Thr
GlycanIUPAC_T33 542-545 "http://rdf.glycoinfo.org/glycan/G40829OF" denotes Thr
GlycanIUPAC_T34 398-401 "http://rdf.glycoinfo.org/glycan/G29274DI" denotes Thr
GlycanIUPAC_T35 542-545 "http://rdf.glycoinfo.org/glycan/G29274DI" denotes Thr
GlycanIUPAC_T36 398-401 "http://rdf.glycoinfo.org/glycan/G50601AY" denotes Thr
GlycanIUPAC_T37 542-545 "http://rdf.glycoinfo.org/glycan/G50601AY" denotes Thr
GlycanIUPAC_T38 398-401 "http://rdf.glycoinfo.org/glycan/G52865ZM" denotes Thr
GlycanIUPAC_T39 542-545 "http://rdf.glycoinfo.org/glycan/G52865ZM" denotes Thr
GlycanIUPAC_T40 398-401 "http://rdf.glycoinfo.org/glycan/G73633QJ" denotes Thr
GlycanIUPAC_T41 542-545 "http://rdf.glycoinfo.org/glycan/G73633QJ" denotes Thr
GlycanIUPAC_T42 398-401 "http://rdf.glycoinfo.org/glycan/G33319MN" denotes Thr
GlycanIUPAC_T43 542-545 "http://rdf.glycoinfo.org/glycan/G33319MN" denotes Thr
GlycanIUPAC_T44 398-401 "http://rdf.glycoinfo.org/glycan/G94717IQ" denotes Thr
GlycanIUPAC_T45 542-545 "http://rdf.glycoinfo.org/glycan/G94717IQ" denotes Thr
GlycanIUPAC_T46 398-401 "http://rdf.glycoinfo.org/glycan/G50452ZL" denotes Thr
GlycanIUPAC_T47 542-545 "http://rdf.glycoinfo.org/glycan/G50452ZL" denotes Thr
GlycanIUPAC_T48 398-401 "http://rdf.glycoinfo.org/glycan/G90753WM" denotes Thr
GlycanIUPAC_T49 542-545 "http://rdf.glycoinfo.org/glycan/G90753WM" denotes Thr
GlycanIUPAC_T50 398-401 "http://rdf.glycoinfo.org/glycan/G27898GL" denotes Thr
GlycanIUPAC_T51 542-545 "http://rdf.glycoinfo.org/glycan/G27898GL" denotes Thr
GlycanIUPAC_T52 398-401 "http://rdf.glycoinfo.org/glycan/G03827YH" denotes Thr
GlycanIUPAC_T53 542-545 "http://rdf.glycoinfo.org/glycan/G03827YH" denotes Thr
GlycanIUPAC_T54 398-401 "http://rdf.glycoinfo.org/glycan/G64500BA" denotes Thr
GlycanIUPAC_T55 542-545 "http://rdf.glycoinfo.org/glycan/G64500BA" denotes Thr
GlycanIUPAC_T56 398-401 "http://rdf.glycoinfo.org/glycan/G89743XV" denotes Thr
GlycanIUPAC_T57 542-545 "http://rdf.glycoinfo.org/glycan/G89743XV" denotes Thr
GlycanIUPAC_T58 398-401 "http://rdf.glycoinfo.org/glycan/G62576QG" denotes Thr
GlycanIUPAC_T59 542-545 "http://rdf.glycoinfo.org/glycan/G62576QG" denotes Thr
GlycanIUPAC_T60 398-401 "http://rdf.glycoinfo.org/glycan/G70212CQ" denotes Thr
GlycanIUPAC_T61 542-545 "http://rdf.glycoinfo.org/glycan/G70212CQ" denotes Thr
GlycanIUPAC_T62 398-401 "http://rdf.glycoinfo.org/glycan/G74708KP" denotes Thr
GlycanIUPAC_T63 542-545 "http://rdf.glycoinfo.org/glycan/G74708KP" denotes Thr
GlycanIUPAC_T64 398-401 "http://rdf.glycoinfo.org/glycan/G02394PC" denotes Thr
GlycanIUPAC_T65 542-545 "http://rdf.glycoinfo.org/glycan/G02394PC" denotes Thr
GlycanIUPAC_T66 398-401 "http://rdf.glycoinfo.org/glycan/G57814GP" denotes Thr
GlycanIUPAC_T67 542-545 "http://rdf.glycoinfo.org/glycan/G57814GP" denotes Thr
GlycanIUPAC_T68 398-401 "http://rdf.glycoinfo.org/glycan/G81521LC" denotes Thr
GlycanIUPAC_T69 542-545 "http://rdf.glycoinfo.org/glycan/G81521LC" denotes Thr
GlycanIUPAC_T70 398-401 "http://rdf.glycoinfo.org/glycan/G42918SL" denotes Thr
GlycanIUPAC_T71 542-545 "http://rdf.glycoinfo.org/glycan/G42918SL" denotes Thr
GlycanIUPAC_T72 398-401 "http://rdf.glycoinfo.org/glycan/G95238FE" denotes Thr
GlycanIUPAC_T73 542-545 "http://rdf.glycoinfo.org/glycan/G95238FE" denotes Thr
GlycanIUPAC_T74 398-401 "http://rdf.glycoinfo.org/glycan/G28403TD" denotes Thr
GlycanIUPAC_T75 542-545 "http://rdf.glycoinfo.org/glycan/G28403TD" denotes Thr
GlycanIUPAC_T76 398-401 "http://rdf.glycoinfo.org/glycan/G30379UC" denotes Thr
GlycanIUPAC_T77 542-545 "http://rdf.glycoinfo.org/glycan/G30379UC" denotes Thr
GlycanIUPAC_T78 398-401 "http://rdf.glycoinfo.org/glycan/G83583TH" denotes Thr
GlycanIUPAC_T79 542-545 "http://rdf.glycoinfo.org/glycan/G83583TH" denotes Thr
GlycanIUPAC_T80 398-401 "http://rdf.glycoinfo.org/glycan/G59548EJ" denotes Thr
GlycanIUPAC_T81 542-545 "http://rdf.glycoinfo.org/glycan/G59548EJ" denotes Thr
GlycanIUPAC_T82 398-401 "http://rdf.glycoinfo.org/glycan/G47410OV" denotes Thr
GlycanIUPAC_T83 542-545 "http://rdf.glycoinfo.org/glycan/G47410OV" denotes Thr
GlycanIUPAC_T84 398-401 "http://rdf.glycoinfo.org/glycan/G88663EK" denotes Thr
GlycanIUPAC_T85 542-545 "http://rdf.glycoinfo.org/glycan/G88663EK" denotes Thr
GlycanIUPAC_T86 398-401 "http://rdf.glycoinfo.org/glycan/G90684PG" denotes Thr
GlycanIUPAC_T87 542-545 "http://rdf.glycoinfo.org/glycan/G90684PG" denotes Thr
GlycanIUPAC_T88 398-401 "http://rdf.glycoinfo.org/glycan/G44881OW" denotes Thr
GlycanIUPAC_T89 542-545 "http://rdf.glycoinfo.org/glycan/G44881OW" denotes Thr
GlycanIUPAC_T90 398-401 "http://rdf.glycoinfo.org/glycan/G54691YO" denotes Thr
GlycanIUPAC_T91 542-545 "http://rdf.glycoinfo.org/glycan/G54691YO" denotes Thr
GlycanIUPAC_T92 398-401 "http://rdf.glycoinfo.org/glycan/G19289PT" denotes Thr
GlycanIUPAC_T93 542-545 "http://rdf.glycoinfo.org/glycan/G19289PT" denotes Thr
GlycanIUPAC_T94 398-401 "http://rdf.glycoinfo.org/glycan/G23779KC" denotes Thr
GlycanIUPAC_T95 542-545 "http://rdf.glycoinfo.org/glycan/G23779KC" denotes Thr
GlycanIUPAC_T96 398-401 "http://rdf.glycoinfo.org/glycan/G94729UX" denotes Thr
GlycanIUPAC_T97 542-545 "http://rdf.glycoinfo.org/glycan/G94729UX" denotes Thr
GlycanIUPAC_T98 398-401 "http://rdf.glycoinfo.org/glycan/G34038TZ" denotes Thr
GlycanIUPAC_T99 542-545 "http://rdf.glycoinfo.org/glycan/G34038TZ" denotes Thr
GlycanIUPAC_T100 398-401 "http://rdf.glycoinfo.org/glycan/G90659JR" denotes Thr
GlycanIUPAC_T101 542-545 "http://rdf.glycoinfo.org/glycan/G90659JR" denotes Thr
GlycanIUPAC_T102 398-401 "http://rdf.glycoinfo.org/glycan/G74977VW" denotes Thr
GlycanIUPAC_T103 542-545 "http://rdf.glycoinfo.org/glycan/G74977VW" denotes Thr
GlycanIUPAC_T104 398-401 "http://rdf.glycoinfo.org/glycan/G42696WA" denotes Thr
GlycanIUPAC_T105 542-545 "http://rdf.glycoinfo.org/glycan/G42696WA" denotes Thr
GlycanIUPAC_T106 398-401 "http://rdf.glycoinfo.org/glycan/G82531XS" denotes Thr
GlycanIUPAC_T107 542-545 "http://rdf.glycoinfo.org/glycan/G82531XS" denotes Thr
GlycanIUPAC_T108 398-401 "http://rdf.glycoinfo.org/glycan/G47639GO" denotes Thr
GlycanIUPAC_T109 542-545 "http://rdf.glycoinfo.org/glycan/G47639GO" denotes Thr
GlycanIUPAC_T110 398-401 "http://rdf.glycoinfo.org/glycan/G69282NX" denotes Thr
GlycanIUPAC_T111 542-545 "http://rdf.glycoinfo.org/glycan/G69282NX" denotes Thr
GlycanIUPAC_T112 398-401 "http://rdf.glycoinfo.org/glycan/G49708JS" denotes Thr
GlycanIUPAC_T113 542-545 "http://rdf.glycoinfo.org/glycan/G49708JS" denotes Thr
GlycanIUPAC_T114 398-401 "http://rdf.glycoinfo.org/glycan/G63317ON" denotes Thr
GlycanIUPAC_T115 542-545 "http://rdf.glycoinfo.org/glycan/G63317ON" denotes Thr
GlycanIUPAC_T116 398-401 "http://rdf.glycoinfo.org/glycan/G60349YI" denotes Thr
GlycanIUPAC_T117 542-545 "http://rdf.glycoinfo.org/glycan/G60349YI" denotes Thr
GlycanIUPAC_T118 398-401 "http://rdf.glycoinfo.org/glycan/G81659AQ" denotes Thr
GlycanIUPAC_T119 542-545 "http://rdf.glycoinfo.org/glycan/G81659AQ" denotes Thr
GlycanIUPAC_T120 398-401 "http://rdf.glycoinfo.org/glycan/G16289GE" denotes Thr
GlycanIUPAC_T121 542-545 "http://rdf.glycoinfo.org/glycan/G16289GE" denotes Thr
GlycanIUPAC_T122 398-401 "http://rdf.glycoinfo.org/glycan/G69569AG" denotes Thr
GlycanIUPAC_T123 542-545 "http://rdf.glycoinfo.org/glycan/G69569AG" denotes Thr
GlycanIUPAC_T124 398-401 "http://rdf.glycoinfo.org/glycan/G16884LK" denotes Thr
GlycanIUPAC_T125 542-545 "http://rdf.glycoinfo.org/glycan/G16884LK" denotes Thr
GlycanIUPAC_T126 398-401 "http://rdf.glycoinfo.org/glycan/G23450NH" denotes Thr
GlycanIUPAC_T127 542-545 "http://rdf.glycoinfo.org/glycan/G23450NH" denotes Thr
GlycanIUPAC_T128 398-401 "http://rdf.glycoinfo.org/glycan/G85052FR" denotes Thr
GlycanIUPAC_T129 542-545 "http://rdf.glycoinfo.org/glycan/G85052FR" denotes Thr
GlycanIUPAC_T130 398-401 "http://rdf.glycoinfo.org/glycan/G55485RI" denotes Thr
GlycanIUPAC_T131 542-545 "http://rdf.glycoinfo.org/glycan/G55485RI" denotes Thr
GlycanIUPAC_T132 398-401 "http://rdf.glycoinfo.org/glycan/G80596GL" denotes Thr
GlycanIUPAC_T133 542-545 "http://rdf.glycoinfo.org/glycan/G80596GL" denotes Thr
GlycanIUPAC_T134 398-401 "http://rdf.glycoinfo.org/glycan/G39656RU" denotes Thr
GlycanIUPAC_T135 542-545 "http://rdf.glycoinfo.org/glycan/G39656RU" denotes Thr
GlycanIUPAC_T136 398-401 "http://rdf.glycoinfo.org/glycan/G71284FA" denotes Thr
GlycanIUPAC_T137 542-545 "http://rdf.glycoinfo.org/glycan/G71284FA" denotes Thr
GlycanIUPAC_T138 398-401 "http://rdf.glycoinfo.org/glycan/G42091PK" denotes Thr
GlycanIUPAC_T139 542-545 "http://rdf.glycoinfo.org/glycan/G42091PK" denotes Thr
GlycanIUPAC_T140 398-401 "http://rdf.glycoinfo.org/glycan/G38798SL" denotes Thr
GlycanIUPAC_T141 542-545 "http://rdf.glycoinfo.org/glycan/G38798SL" denotes Thr
GlycanIUPAC_T142 398-401 "http://rdf.glycoinfo.org/glycan/G36670NA" denotes Thr
GlycanIUPAC_T143 542-545 "http://rdf.glycoinfo.org/glycan/G36670NA" denotes Thr
GlycanIUPAC_T144 398-401 "http://rdf.glycoinfo.org/glycan/G91582QV" denotes Thr
GlycanIUPAC_T145 542-545 "http://rdf.glycoinfo.org/glycan/G91582QV" denotes Thr
GlycanIUPAC_T146 398-401 "http://rdf.glycoinfo.org/glycan/G28625IE" denotes Thr
GlycanIUPAC_T147 542-545 "http://rdf.glycoinfo.org/glycan/G28625IE" denotes Thr
GlycanIUPAC_T148 398-401 "http://rdf.glycoinfo.org/glycan/G81304ZT" denotes Thr
GlycanIUPAC_T149 542-545 "http://rdf.glycoinfo.org/glycan/G81304ZT" denotes Thr
GlycanIUPAC_T150 398-401 "http://rdf.glycoinfo.org/glycan/G82883BK" denotes Thr
GlycanIUPAC_T151 542-545 "http://rdf.glycoinfo.org/glycan/G82883BK" denotes Thr
GlycanIUPAC_T152 398-401 "http://rdf.glycoinfo.org/glycan/G46290DK" denotes Thr
GlycanIUPAC_T153 542-545 "http://rdf.glycoinfo.org/glycan/G46290DK" denotes Thr
GlycanIUPAC_T154 398-401 "http://rdf.glycoinfo.org/glycan/G68202TJ" denotes Thr
GlycanIUPAC_T155 542-545 "http://rdf.glycoinfo.org/glycan/G68202TJ" denotes Thr
GlycanIUPAC_T156 398-401 "http://rdf.glycoinfo.org/glycan/G39722QK" denotes Thr
GlycanIUPAC_T157 542-545 "http://rdf.glycoinfo.org/glycan/G39722QK" denotes Thr
GlycanIUPAC_T158 398-401 "http://rdf.glycoinfo.org/glycan/G76637LW" denotes Thr
GlycanIUPAC_T159 542-545 "http://rdf.glycoinfo.org/glycan/G76637LW" denotes Thr
GlycanIUPAC_T160 398-401 "http://rdf.glycoinfo.org/glycan/G51390WF" denotes Thr
GlycanIUPAC_T161 542-545 "http://rdf.glycoinfo.org/glycan/G51390WF" denotes Thr
GlycanIUPAC_T162 398-401 "http://rdf.glycoinfo.org/glycan/G35392PX" denotes Thr
GlycanIUPAC_T163 542-545 "http://rdf.glycoinfo.org/glycan/G35392PX" denotes Thr
GlycanIUPAC_T164 398-401 "http://rdf.glycoinfo.org/glycan/G27815EZ" denotes Thr
GlycanIUPAC_T165 542-545 "http://rdf.glycoinfo.org/glycan/G27815EZ" denotes Thr
GlycanIUPAC_T166 398-401 "http://rdf.glycoinfo.org/glycan/G64374OT" denotes Thr
GlycanIUPAC_T167 542-545 "http://rdf.glycoinfo.org/glycan/G64374OT" denotes Thr
GlycanIUPAC_T168 398-401 "http://rdf.glycoinfo.org/glycan/G58333PU" denotes Thr
GlycanIUPAC_T169 542-545 "http://rdf.glycoinfo.org/glycan/G58333PU" denotes Thr
GlycanIUPAC_T170 398-401 "http://rdf.glycoinfo.org/glycan/G19695IE" denotes Thr
GlycanIUPAC_T171 542-545 "http://rdf.glycoinfo.org/glycan/G19695IE" denotes Thr
GlycanIUPAC_T172 398-401 "http://rdf.glycoinfo.org/glycan/G65617GK" denotes Thr
GlycanIUPAC_T173 542-545 "http://rdf.glycoinfo.org/glycan/G65617GK" denotes Thr
GlycanIUPAC_T174 398-401 "http://rdf.glycoinfo.org/glycan/G29832KZ" denotes Thr
GlycanIUPAC_T175 542-545 "http://rdf.glycoinfo.org/glycan/G29832KZ" denotes Thr
GlycanIUPAC_T176 398-401 "http://rdf.glycoinfo.org/glycan/G05333AM" denotes Thr
GlycanIUPAC_T177 542-545 "http://rdf.glycoinfo.org/glycan/G05333AM" denotes Thr
GlycanIUPAC_T178 398-401 "http://rdf.glycoinfo.org/glycan/G46130CG" denotes Thr
GlycanIUPAC_T179 542-545 "http://rdf.glycoinfo.org/glycan/G46130CG" denotes Thr
GlycanIUPAC_T180 398-401 "http://rdf.glycoinfo.org/glycan/G57766RG" denotes Thr
GlycanIUPAC_T181 542-545 "http://rdf.glycoinfo.org/glycan/G57766RG" denotes Thr
GlycanIUPAC_T182 398-401 "http://rdf.glycoinfo.org/glycan/G03334HH" denotes Thr
GlycanIUPAC_T183 542-545 "http://rdf.glycoinfo.org/glycan/G03334HH" denotes Thr
GlycanIUPAC_T184 398-401 "http://rdf.glycoinfo.org/glycan/G46094SV" denotes Thr
GlycanIUPAC_T185 542-545 "http://rdf.glycoinfo.org/glycan/G46094SV" denotes Thr
GlycanIUPAC_T186 398-401 "http://rdf.glycoinfo.org/glycan/G98365FX" denotes Thr
GlycanIUPAC_T187 542-545 "http://rdf.glycoinfo.org/glycan/G98365FX" denotes Thr
GlycanIUPAC_T188 398-401 "http://rdf.glycoinfo.org/glycan/G85392EJ" denotes Thr
GlycanIUPAC_T189 542-545 "http://rdf.glycoinfo.org/glycan/G85392EJ" denotes Thr
GlycanIUPAC_T190 398-401 "http://rdf.glycoinfo.org/glycan/G59996WL" denotes Thr
GlycanIUPAC_T191 542-545 "http://rdf.glycoinfo.org/glycan/G59996WL" denotes Thr
GlycanIUPAC_T192 398-401 "http://rdf.glycoinfo.org/glycan/G49141OD" denotes Thr
GlycanIUPAC_T193 542-545 "http://rdf.glycoinfo.org/glycan/G49141OD" denotes Thr
GlycanIUPAC_T194 398-401 "http://rdf.glycoinfo.org/glycan/G88793VU" denotes Thr
GlycanIUPAC_T195 542-545 "http://rdf.glycoinfo.org/glycan/G88793VU" denotes Thr
GlycanIUPAC_T196 398-401 "http://rdf.glycoinfo.org/glycan/G88801WQ" denotes Thr
GlycanIUPAC_T197 542-545 "http://rdf.glycoinfo.org/glycan/G88801WQ" denotes Thr
GlycanIUPAC_T198 398-401 "http://rdf.glycoinfo.org/glycan/G61612EQ" denotes Thr
GlycanIUPAC_T199 542-545 "http://rdf.glycoinfo.org/glycan/G61612EQ" denotes Thr
GlycanIUPAC_T200 398-401 "http://rdf.glycoinfo.org/glycan/G23181BS" denotes Thr
GlycanIUPAC_T201 542-545 "http://rdf.glycoinfo.org/glycan/G23181BS" denotes Thr
GlycanIUPAC_T202 398-401 "http://rdf.glycoinfo.org/glycan/G77428YW" denotes Thr
GlycanIUPAC_T203 542-545 "http://rdf.glycoinfo.org/glycan/G77428YW" denotes Thr
GlycanIUPAC_T204 398-401 "http://rdf.glycoinfo.org/glycan/G06824UZ" denotes Thr
GlycanIUPAC_T205 542-545 "http://rdf.glycoinfo.org/glycan/G06824UZ" denotes Thr
GlycanIUPAC_T206 398-401 "http://rdf.glycoinfo.org/glycan/G15142RK" denotes Thr
GlycanIUPAC_T207 542-545 "http://rdf.glycoinfo.org/glycan/G15142RK" denotes Thr
GlycanIUPAC_T208 398-401 "http://rdf.glycoinfo.org/glycan/G18198RM" denotes Thr
GlycanIUPAC_T209 542-545 "http://rdf.glycoinfo.org/glycan/G18198RM" denotes Thr
GlycanIUPAC_T210 398-401 "http://rdf.glycoinfo.org/glycan/G70750SS" denotes Thr
GlycanIUPAC_T211 542-545 "http://rdf.glycoinfo.org/glycan/G70750SS" denotes Thr
GlycanIUPAC_T212 398-401 "http://rdf.glycoinfo.org/glycan/G04998YJ" denotes Thr
GlycanIUPAC_T213 542-545 "http://rdf.glycoinfo.org/glycan/G04998YJ" denotes Thr
GlycanIUPAC_T214 398-401 "http://rdf.glycoinfo.org/glycan/G44379HX" denotes Thr
GlycanIUPAC_T215 542-545 "http://rdf.glycoinfo.org/glycan/G44379HX" denotes Thr
GlycanIUPAC_T216 398-401 "http://rdf.glycoinfo.org/glycan/G25683ZO" denotes Thr
GlycanIUPAC_T217 542-545 "http://rdf.glycoinfo.org/glycan/G25683ZO" denotes Thr
GlycanIUPAC_T218 398-401 "http://rdf.glycoinfo.org/glycan/G35036BA" denotes Thr
GlycanIUPAC_T219 542-545 "http://rdf.glycoinfo.org/glycan/G35036BA" denotes Thr
GlycanIUPAC_T220 398-401 "http://rdf.glycoinfo.org/glycan/G98129RB" denotes Thr
GlycanIUPAC_T221 542-545 "http://rdf.glycoinfo.org/glycan/G98129RB" denotes Thr
GlycanIUPAC_T222 398-401 "http://rdf.glycoinfo.org/glycan/G00134PL" denotes Thr
GlycanIUPAC_T223 542-545 "http://rdf.glycoinfo.org/glycan/G00134PL" denotes Thr
GlycanIUPAC_T224 398-401 "http://rdf.glycoinfo.org/glycan/G26488SP" denotes Thr
GlycanIUPAC_T225 542-545 "http://rdf.glycoinfo.org/glycan/G26488SP" denotes Thr
GlycanIUPAC_T226 398-401 "http://rdf.glycoinfo.org/glycan/G02441UD" denotes Thr
GlycanIUPAC_T227 542-545 "http://rdf.glycoinfo.org/glycan/G02441UD" denotes Thr
GlycanIUPAC_T228 398-401 "http://rdf.glycoinfo.org/glycan/G21668ZD" denotes Thr
GlycanIUPAC_T229 542-545 "http://rdf.glycoinfo.org/glycan/G21668ZD" denotes Thr
GlycanIUPAC_T230 398-401 "http://rdf.glycoinfo.org/glycan/G67040OT" denotes Thr
GlycanIUPAC_T231 542-545 "http://rdf.glycoinfo.org/glycan/G67040OT" denotes Thr
GlycanIUPAC_T232 398-401 "http://rdf.glycoinfo.org/glycan/G56431YZ" denotes Thr
GlycanIUPAC_T233 542-545 "http://rdf.glycoinfo.org/glycan/G56431YZ" denotes Thr
GlycanIUPAC_T234 398-401 "http://rdf.glycoinfo.org/glycan/G29667IS" denotes Thr
GlycanIUPAC_T235 542-545 "http://rdf.glycoinfo.org/glycan/G29667IS" denotes Thr
GlycanIUPAC_T236 398-401 "http://rdf.glycoinfo.org/glycan/G94122LM" denotes Thr
GlycanIUPAC_T237 542-545 "http://rdf.glycoinfo.org/glycan/G94122LM" denotes Thr
GlycanIUPAC_T238 398-401 "http://rdf.glycoinfo.org/glycan/G93233YT" denotes Thr
GlycanIUPAC_T239 542-545 "http://rdf.glycoinfo.org/glycan/G93233YT" denotes Thr
GlycanIUPAC_T240 398-401 "http://rdf.glycoinfo.org/glycan/G72035WK" denotes Thr
GlycanIUPAC_T241 542-545 "http://rdf.glycoinfo.org/glycan/G72035WK" denotes Thr
GlycanIUPAC_T242 398-401 "http://rdf.glycoinfo.org/glycan/G99855SM" denotes Thr
GlycanIUPAC_T243 542-545 "http://rdf.glycoinfo.org/glycan/G99855SM" denotes Thr
GlycanIUPAC_T244 398-401 "http://rdf.glycoinfo.org/glycan/G48723MN" denotes Thr
GlycanIUPAC_T245 542-545 "http://rdf.glycoinfo.org/glycan/G48723MN" denotes Thr
GlycanIUPAC_T246 398-401 "http://rdf.glycoinfo.org/glycan/G28558MB" denotes Thr
GlycanIUPAC_T247 542-545 "http://rdf.glycoinfo.org/glycan/G28558MB" denotes Thr
GlycanIUPAC_T248 398-401 "http://rdf.glycoinfo.org/glycan/G92768RX" denotes Thr
GlycanIUPAC_T249 542-545 "http://rdf.glycoinfo.org/glycan/G92768RX" denotes Thr
GlycanIUPAC_T250 398-401 "http://rdf.glycoinfo.org/glycan/G70136KU" denotes Thr
GlycanIUPAC_T251 542-545 "http://rdf.glycoinfo.org/glycan/G70136KU" denotes Thr
GlycanIUPAC_T252 398-401 "http://rdf.glycoinfo.org/glycan/G37935YM" denotes Thr
GlycanIUPAC_T253 542-545 "http://rdf.glycoinfo.org/glycan/G37935YM" denotes Thr
GlycanIUPAC_T254 398-401 "http://rdf.glycoinfo.org/glycan/G96902PQ" denotes Thr
GlycanIUPAC_T255 542-545 "http://rdf.glycoinfo.org/glycan/G96902PQ" denotes Thr
GlycanIUPAC_T256 398-401 "http://rdf.glycoinfo.org/glycan/G14015DN" denotes Thr
GlycanIUPAC_T257 542-545 "http://rdf.glycoinfo.org/glycan/G14015DN" denotes Thr
GlycanIUPAC_T258 398-401 "http://rdf.glycoinfo.org/glycan/G83153IV" denotes Thr
GlycanIUPAC_T259 542-545 "http://rdf.glycoinfo.org/glycan/G83153IV" denotes Thr
GlycanIUPAC_T260 398-401 "http://rdf.glycoinfo.org/glycan/G73174QP" denotes Thr
GlycanIUPAC_T261 542-545 "http://rdf.glycoinfo.org/glycan/G73174QP" denotes Thr
GlycanIUPAC_T262 398-401 "http://rdf.glycoinfo.org/glycan/G67188XY" denotes Thr
GlycanIUPAC_T263 542-545 "http://rdf.glycoinfo.org/glycan/G67188XY" denotes Thr
GlycanIUPAC_T264 398-401 "http://rdf.glycoinfo.org/glycan/G35093GE" denotes Thr
GlycanIUPAC_T265 542-545 "http://rdf.glycoinfo.org/glycan/G35093GE" denotes Thr
GlycanIUPAC_T266 398-401 "http://rdf.glycoinfo.org/glycan/G13364VQ" denotes Thr
GlycanIUPAC_T267 542-545 "http://rdf.glycoinfo.org/glycan/G13364VQ" denotes Thr
GlycanIUPAC_T268 398-401 "http://rdf.glycoinfo.org/glycan/G72068FB" denotes Thr
GlycanIUPAC_T269 542-545 "http://rdf.glycoinfo.org/glycan/G72068FB" denotes Thr
GlycanIUPAC_T270 398-401 "http://rdf.glycoinfo.org/glycan/G93329DU" denotes Thr
GlycanIUPAC_T271 542-545 "http://rdf.glycoinfo.org/glycan/G93329DU" denotes Thr
GlycanIUPAC_T272 398-401 "http://rdf.glycoinfo.org/glycan/G54073VB" denotes Thr
GlycanIUPAC_T273 542-545 "http://rdf.glycoinfo.org/glycan/G54073VB" denotes Thr
GlycanIUPAC_T274 398-401 "http://rdf.glycoinfo.org/glycan/G41447UI" denotes Thr
GlycanIUPAC_T275 542-545 "http://rdf.glycoinfo.org/glycan/G41447UI" denotes Thr
GlycanIUPAC_T276 398-401 "http://rdf.glycoinfo.org/glycan/G85878MY" denotes Thr
GlycanIUPAC_T277 542-545 "http://rdf.glycoinfo.org/glycan/G85878MY" denotes Thr
GlycanIUPAC_T278 398-401 "http://rdf.glycoinfo.org/glycan/G92835HR" denotes Thr
GlycanIUPAC_T279 542-545 "http://rdf.glycoinfo.org/glycan/G92835HR" denotes Thr
GlycanIUPAC_T280 398-401 "http://rdf.glycoinfo.org/glycan/G34845TQ" denotes Thr
GlycanIUPAC_T281 542-545 "http://rdf.glycoinfo.org/glycan/G34845TQ" denotes Thr
GlycanIUPAC_T282 398-401 "http://rdf.glycoinfo.org/glycan/G38916XK" denotes Thr
GlycanIUPAC_T283 542-545 "http://rdf.glycoinfo.org/glycan/G38916XK" denotes Thr
GlycanIUPAC_T284 398-401 "http://rdf.glycoinfo.org/glycan/G87709OA" denotes Thr
GlycanIUPAC_T285 542-545 "http://rdf.glycoinfo.org/glycan/G87709OA" denotes Thr
GlycanIUPAC_T286 398-401 "http://rdf.glycoinfo.org/glycan/G46661GX" denotes Thr
GlycanIUPAC_T287 542-545 "http://rdf.glycoinfo.org/glycan/G46661GX" denotes Thr
GlycanIUPAC_T288 398-401 "http://rdf.glycoinfo.org/glycan/G53431DX" denotes Thr
GlycanIUPAC_T289 542-545 "http://rdf.glycoinfo.org/glycan/G53431DX" denotes Thr
GlycanIUPAC_T290 398-401 "http://rdf.glycoinfo.org/glycan/G71815PL" denotes Thr
GlycanIUPAC_T291 542-545 "http://rdf.glycoinfo.org/glycan/G71815PL" denotes Thr
GlycanIUPAC_T292 398-401 "http://rdf.glycoinfo.org/glycan/G97173UR" denotes Thr
GlycanIUPAC_T293 542-545 "http://rdf.glycoinfo.org/glycan/G97173UR" denotes Thr
GlycanIUPAC_T294 398-401 "http://rdf.glycoinfo.org/glycan/G53453JD" denotes Thr
GlycanIUPAC_T295 542-545 "http://rdf.glycoinfo.org/glycan/G53453JD" denotes Thr
GlycanIUPAC_T296 398-401 "http://rdf.glycoinfo.org/glycan/G48975CP" denotes Thr
GlycanIUPAC_T297 542-545 "http://rdf.glycoinfo.org/glycan/G48975CP" denotes Thr
GlycanIUPAC_T298 398-401 "http://rdf.glycoinfo.org/glycan/G87775XT" denotes Thr
GlycanIUPAC_T299 542-545 "http://rdf.glycoinfo.org/glycan/G87775XT" denotes Thr
GlycanIUPAC_T300 398-401 "http://rdf.glycoinfo.org/glycan/G48463GY" denotes Thr
GlycanIUPAC_T301 542-545 "http://rdf.glycoinfo.org/glycan/G48463GY" denotes Thr
GlycanIUPAC_T302 398-401 "http://rdf.glycoinfo.org/glycan/G54042BQ" denotes Thr
GlycanIUPAC_T303 542-545 "http://rdf.glycoinfo.org/glycan/G54042BQ" denotes Thr
GlycanIUPAC_T304 398-401 "http://rdf.glycoinfo.org/glycan/G99993MV" denotes Thr
GlycanIUPAC_T305 542-545 "http://rdf.glycoinfo.org/glycan/G99993MV" denotes Thr
GlycanIUPAC_T306 398-401 "http://rdf.glycoinfo.org/glycan/G81407LL" denotes Thr
GlycanIUPAC_T307 542-545 "http://rdf.glycoinfo.org/glycan/G81407LL" denotes Thr
GlycanIUPAC_T308 398-401 "http://rdf.glycoinfo.org/glycan/G46430YF" denotes Thr
GlycanIUPAC_T309 542-545 "http://rdf.glycoinfo.org/glycan/G46430YF" denotes Thr
GlycanIUPAC_T310 398-401 "http://rdf.glycoinfo.org/glycan/G86548QQ" denotes Thr
GlycanIUPAC_T311 542-545 "http://rdf.glycoinfo.org/glycan/G86548QQ" denotes Thr
GlycanIUPAC_T312 398-401 "http://rdf.glycoinfo.org/glycan/G25645HZ" denotes Thr
GlycanIUPAC_T313 542-545 "http://rdf.glycoinfo.org/glycan/G25645HZ" denotes Thr
GlycanIUPAC_T314 398-401 "http://rdf.glycoinfo.org/glycan/G73880WZ" denotes Thr
GlycanIUPAC_T315 542-545 "http://rdf.glycoinfo.org/glycan/G73880WZ" denotes Thr
GlycanIUPAC_T316 398-401 "http://rdf.glycoinfo.org/glycan/G12979RT" denotes Thr
GlycanIUPAC_T317 542-545 "http://rdf.glycoinfo.org/glycan/G12979RT" denotes Thr
GlycanIUPAC_T318 398-401 "http://rdf.glycoinfo.org/glycan/G36146RU" denotes Thr
GlycanIUPAC_T319 542-545 "http://rdf.glycoinfo.org/glycan/G36146RU" denotes Thr
GlycanIUPAC_T320 398-401 "http://rdf.glycoinfo.org/glycan/G23944RZ" denotes Thr
GlycanIUPAC_T321 542-545 "http://rdf.glycoinfo.org/glycan/G23944RZ" denotes Thr
GlycanIUPAC_T322 398-401 "http://rdf.glycoinfo.org/glycan/G67041BN" denotes Thr
GlycanIUPAC_T323 542-545 "http://rdf.glycoinfo.org/glycan/G67041BN" denotes Thr
GlycanIUPAC_T324 398-401 "http://rdf.glycoinfo.org/glycan/G95408HX" denotes Thr
GlycanIUPAC_T325 542-545 "http://rdf.glycoinfo.org/glycan/G95408HX" denotes Thr
GlycanIUPAC_T326 398-401 "http://rdf.glycoinfo.org/glycan/G31094CC" denotes Thr
GlycanIUPAC_T327 542-545 "http://rdf.glycoinfo.org/glycan/G31094CC" denotes Thr
GlycanIUPAC_T328 398-401 "http://rdf.glycoinfo.org/glycan/G99598GU" denotes Thr
GlycanIUPAC_T329 542-545 "http://rdf.glycoinfo.org/glycan/G99598GU" denotes Thr
GlycanIUPAC_T330 398-401 "http://rdf.glycoinfo.org/glycan/G94072IC" denotes Thr
GlycanIUPAC_T331 542-545 "http://rdf.glycoinfo.org/glycan/G94072IC" denotes Thr
GlycanIUPAC_T332 398-401 "http://rdf.glycoinfo.org/glycan/G09523ZS" denotes Thr
GlycanIUPAC_T333 542-545 "http://rdf.glycoinfo.org/glycan/G09523ZS" denotes Thr

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 37-43 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 231-237 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 578-584 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 719-725 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 1415-1421 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 37-50 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T2 231-244 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T3 578-591 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T4 719-732 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T5 1199-1231 Disease denotes severe combined immunodeficiency http://purl.obolibrary.org/obo/MONDO_0015974
T6 1233-1237 Disease denotes SCID http://purl.obolibrary.org/obo/MONDO_0015974
T7 1415-1428 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 37-50 Phenotype denotes breast cancer HP:0003002
T2 231-244 Phenotype denotes breast cancer HP:0003002
T3 578-591 Phenotype denotes breast cancer HP:0003002
T4 719-732 Phenotype denotes breast cancer HP:0003002
T5 1182-1188 Phenotype denotes tumour HP:0002664
T6 1199-1231 Phenotype denotes severe combined immunodeficiency HP:0004430
T7 1233-1237 Phenotype denotes SCID HP:0004430
T8 1415-1428 Phenotype denotes breast cancer HP:0003002

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 369-375 Glycan denotes Neu5Ac https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR
T2 781-791 Glycan denotes Tn antigen https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 774-791 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-Tn antigen http://www.glycoepitope.jp/epitopes/EP0022
T2 793-796 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes STn http://www.glycoepitope.jp/epitopes/EP0022
T3 1141-1144 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes STn http://www.glycoepitope.jp/epitopes/EP0022

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 37-50 Phenotype denotes breast cancer HP:0003002
T2 231-244 Phenotype denotes breast cancer HP:0003002
T3 578-591 Phenotype denotes breast cancer HP:0003002
T4 719-732 Phenotype denotes breast cancer HP:0003002
T5 1182-1188 Phenotype denotes tumour HP:0002664
T6 1199-1231 Phenotype denotes severe combined immunodeficiency HP:0004430
T7 1233-1237 Phenotype denotes SCID HP:0004430
T8 1415-1428 Phenotype denotes breast cancer HP:0003002

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 37-50 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T3 231-244 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T5 578-591 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T7 719-732 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T9 1182-1188 Disease denotes tumour MONDO:0005070
T10 1199-1231 Disease denotes severe combined immunodeficiency MONDO:0015974
T11 1233-1237 Disease denotes SCID MONDO:0015974
T12 1415-1428 Disease denotes breast cancer MONDO:0004989|MONDO:0007254

GlyCosmos15-CL

Id Subject Object Predicate Lexical cue cl_id
T1 44-56 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064
T2 585-596 Cell denotes cancer cell http://purl.obolibrary.org/obo/CL:0001064
T3 726-737 Cell denotes cancer cell http://purl.obolibrary.org/obo/CL:0001064
T4 1422-1434 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 37-43 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T2 231-237 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 578-584 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T4 719-725 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T5 1415-1421 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
TextSentencer_T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
TextSentencer_T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
TextSentencer_T4 557-645 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn.
TextSentencer_T5 646-809 Sentence denotes We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
TextSentencer_T6 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
TextSentencer_T7 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
TextSentencer_T8 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
TextSentencer_T9 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.
T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
T4 557-809 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn. We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
T5 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
T6 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
T7 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
T8 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.
T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
T4 557-645 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn.
T5 646-809 Sentence denotes We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
T6 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
T7 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
T8 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
T9 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-139 Sentence denotes ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
T2 140-289 Sentence denotes Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis.
T3 290-556 Sentence denotes Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAcalpha2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAcalpha1-O-Ser/Thr alpha2,6-sialyltransferase (EC 2.4.99.3) (ST6GalNAc I), which transfers a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure.
T4 557-809 Sentence denotes However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn. We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression.
T5 810-960 Sentence denotes We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells.
T6 961-1130 Sentence denotes We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231.
T7 1131-1244 Sentence denotes Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice.
T8 1245-1435 Sentence denotes These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 774-791 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-Tn antigen http://www.glycoepitope.jp/epitopes/EP0022
T2 793-796 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes STn http://www.glycoepitope.jp/epitopes/EP0022
T3 1141-1144 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes STn http://www.glycoepitope.jp/epitopes/EP0022

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 713-718 OrganismTaxon denotes human 9606
T2 1239-1243 OrganismTaxon denotes mice 10088

GlyCosmos15-FMA

Id Subject Object Predicate Lexical cue db_id
T1 37-43 Body_part denotes breast FMA:9601
T2 231-237 Body_part denotes breast FMA:9601
T3 578-584 Body_part denotes breast FMA:9601
T4 719-725 Body_part denotes breast FMA:9601
T5 1415-1421 Body_part denotes breast FMA:9601

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 369-375 Glycan denotes Neu5Ac https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR
T2 774-791 Glycan denotes sialyl-Tn antigen https://api.glycosmos.org/wurcs2image/latest/png/binary/G36123IU
T3 793-796 Glycan denotes STn https://api.glycosmos.org/wurcs2image/latest/png/binary/G36123IU
T4 1141-1144 Glycan denotes STn https://api.glycosmos.org/wurcs2image/latest/png/binary/G36123IU

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 713-718 OrganismTaxon denotes human 9606
T2 1239-1243 OrganismTaxon denotes mice 10088

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 37-43 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T2 231-237 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 578-584 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T4 719-725 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T5 1415-1421 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310

CL-cell

Id Subject Object Predicate Lexical cue cl_id
T1 44-56 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064
T2 585-596 Cell denotes cancer cell http://purl.obolibrary.org/obo/CL:0001064
T3 726-737 Cell denotes cancer cell http://purl.obolibrary.org/obo/CL:0001064
T4 1422-1434 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064